At a glance
ClinicalIndex Comparison RecordN/ACompleted· 17 enrolled
Drug / intervention
Slow sodium tablets +1 moredrug
Likely dose
Slow sodium tablets 2300 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Efficacy of Dietary Sodium Restriction of Improving Vascular Endothelial Function in Middle Aged and Older Adults
In Brief
A clinical study evaluating Slow sodium tablets and placebo for Hypertension. Completed, enrolled 17 participants across 1 site.
Detailed Summary
The investigators hypothesize that reducing salt in the diet will improve the function of blood vessels in middle aged and older adults with moderately elevated systolic blood pressure, by increasing the amount of BH4 and nitric oxide in your blood vessels and reducing the amount of oxidative stress.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHypertension
CountriesUnited States
CollaboratorsNational Institute on Aging (NIA)
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartFeb 2009
Primary CompletionJan 2012
First PostedMar 2012
TodayJul 2026
First PostedMar 29, 2012
Enrollment StartFeb 1, 2009
Primary CompletionJan 1, 2012
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 14.3 years ago
Interventions
Slow sodium tabletsdrug
The normal salt condition is maintained with 2300 mg / day in the form of slowly released salt (NaCl) tablets.
placeboother
Placebo tablets are administered to maintain the low sodium condition.